Today, the Honourable Mark Holland, Minister of Health, announced a new appointment to the Patented Medicine Prices Review Board (PMPRB). Following a merit-based selection process, Peter Moreland-Giraldeau has been appointed to the Board for a five-year term.
The Government of Canada is committed to appointing highly qualified candidates to best serve the interests of Canadians and is committed to open, transparent and merit-based processes for selecting Governor in Council appointees. Appointees play a fundamental role in Canadian democracy as they serve on commissions, boards, Crown corporations, agencies and tribunals across the country.
Mr. Moreland-Giraldeau is a lawyer with a Master of Laws: Common Law (L.L.M) from the University of British Columbia. In his current work for the Appeals Commission for Alberta Workers' Compensation, he provides legal advice to the Commission's General Counsel, Commissioners and Executive. He is also currently the Chair of the Canmore Subdivision and Development Appeal Board.
The PMPRB is an independent quasi-judicial body established by Parliament in 1987 under the Patent Act. As an arm's-length organization of the government, the PMPRB protects the interests of Canadian consumers by ensuring that the prices of patented medicines sold in Canada are not excessive.
